At a glance
- Originator Pfizer
- Class Piperazines
- Mechanism of Action 5-HT1A serotonin receptor agonists; Serotonin 1D receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 15 Mar 2000 No-Development-Reported for Depression in USA (Unknown route)
- 14 Dec 1998 Preclinical development for Depression in USA (Unknown route)